345 Hospital physicians’ and older patients’ agreement with individualised STOPP/START recommendations References 1. O Riordan D, Aubert CE, Walsh KA, et al. Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a crosssectional study. BMJ Open. 2018;8(3):e019003. doi:10.1136/bmjopen-2017-019003 2. Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: A systematic literature review. Eur J Clin Pharmacol. 2015. doi:10.1007/s00228-015-1954-4 3. Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38(1):9-14. doi:10.1345/aph.1D313 4. National Institute for Health and Care Excellence (NICE). Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | 1-recommendations | Guidance and guidelines | NICE. NICE Guidel. 2015;(March). doi:ISBN: 978-1-4731-1057-1 5. Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane database Syst Rev. 2016;2: CD008986. doi:10.1002/14651858. CD008986.pub3 6. Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890-1896. doi:10.1001/archinternmed.2008.3 7. Drenth-van Maanen AC, Leendertse AJ, Jansen PAF, et al. The Systematic Tool to Reduce Inappropriate Prescribing (STRIP): Combining implicit and explicit prescribing tools to improve appropriate prescribing. J Eval Clin Pract. 2018;24(2):317-322. doi:10.1111/ jep.12787 8. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213-218. doi:10.1093/ageing/afu145 9. [9]. O’Mahony D. STOPP/START criteria for potentially inappropriate medications/ potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020. doi:10.1080/17512433.2020.1697676 10. Hoffmann TC, Légaré F, Simmons MB, et al. Shared decision making: What do clinicians need to know and why should they bother? Med J Aust. 2014. doi:10.5694/mja14.00002 11. Coronado-Vázquez V, Gómez-Salgado J, Cerezo-Espinosa de los Monteros J, Ayuso-Murillo D, Ruiz-Frutos C. Shared Decision-Making in Chronic Patients with Polypharmacy: An Interventional Study for Assessing Medication Appropriateness. J Clin Med. 2019. doi:10.3390/jcm8060904 12. Galazzi A, Lusignani M, Chiarelli MT, et al. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. Int J Clin Pharm. 2016. doi:10.1007/s11096-016-0279-4 13. Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Intern Med. 2014. doi:10.1001/ jamainternmed.2014.949 14. Dalton K, O’Mahony D, O’Sullivan D, O’Connor MN, Byrne S. Prescriber Implementation of STOPP/START Recommendations for Hospitalised Older Adults: A Comparison of a Pharmacist Approach and a Physician Approach. Drugs and Aging. 2019. doi:10.1007/ s40266-018-0627-2 4
RkJQdWJsaXNoZXIy MTk4NDMw